Nxera Pharma Co.,Ltd. financial statements, including revenue, expenses, profit, and loss

The total revenue of SOLTF for the last quarter is 51.68 M USD, and it's 132.04% higher compared to the previous quarter. The net income of Q4 23 is -1.47 M USD.